Total Payments
$9,633
2024 Payments
$1,710
Companies
35
Transactions
348
Medicare Patients
7,579
Medicare Billing
$608,710
Payment Breakdown by Category
Food & Beverage$7,852 (81.5%)
Consulting$1,703 (17.7%)
Education$72.00 (0.7%)
Travel$6.50 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,852 | 344 | 81.5% |
| Consulting Fee | $1,703 | 2 | 17.7% |
| Education | $72.00 | 1 | 0.7% |
| Travel and Lodging | $6.50 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $2,938 | 58 | $0 (2024) |
| ABBVIE INC. | $1,148 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $758.71 | 34 | $0 (2024) |
| Medimetriks Pharmaceuticals, Inc. | $541.06 | 17 | $0 (2018) |
| Galderma Laboratories, L.P. | $489.64 | 34 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $454.18 | 22 | $0 (2024) |
| Lilly USA, LLC | $382.99 | 17 | $0 (2024) |
| LEO Pharma Inc. | $346.71 | 21 | $0 (2024) |
| Incyte Corporation | $339.88 | 7 | $0 (2024) |
| Allergan Inc. | $234.22 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,710 | 66 | GENZYME CORPORATION ($600.56) |
| 2023 | $1,181 | 46 | GENZYME CORPORATION ($271.21) |
| 2022 | $780.93 | 23 | GENZYME CORPORATION ($242.95) |
| 2021 | $128.96 | 7 | AbbVie Inc. ($28.20) |
| 2020 | $2,039 | 37 | GENZYME CORPORATION ($1,467) |
| 2019 | $1,143 | 65 | AbbVie, Inc. ($226.30) |
| 2018 | $1,596 | 62 | Medimetriks Pharmaceuticals, Inc. ($485.43) |
| 2017 | $1,054 | 42 | Allergan Inc. ($234.22) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.84 | General |
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.03 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.23 | General |
| Category: Immunology | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.80 | General |
| Category: Immunology | ||||||
| 11/07/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Inflammation & Immunology | ||||||
| 11/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Inflammation & Immunology | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Immunology | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.52 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.43 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.42 | General |
| 09/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $44.43 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,090 | 4,036 | $531,340 | $173,472 |
| 2022 | 22 | 2,063 | 4,034 | $551,040 | $168,785 |
| 2021 | 20 | 1,885 | 3,684 | $474,680 | $152,703 |
| 2020 | 21 | 1,541 | 2,820 | $369,590 | $113,749 |
Total Patients
7,579
Total Services
14,574
Medicare Billing
$608,710
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 620 | 924 | $166,470 | $53,680 | 32.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 240 | 294 | $67,680 | $22,779 | 33.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 232 | 301 | $63,210 | $19,821 | 31.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 305 | 417 | $58,380 | $14,522 | 24.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 45 | 46 | $28,070 | $10,714 | 38.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 54 | 71 | $25,560 | $8,717 | 34.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 232 | 1,549 | $15,630 | $8,150 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 63 | $16,380 | $6,103 | 37.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 70 | 70 | $15,410 | $4,727 | 30.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 68 | 112 | $11,230 | $4,499 | 40.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 25 | 34 | $11,570 | $4,447 | 38.4% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Office | 2023 | 13 | 13 | $8,710 | $3,517 | 40.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 18 | 19 | $4,750 | $1,938 | 40.8% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 16 | 16 | $8,960 | $1,803 | 20.1% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 22 | $7,700 | $1,598 | 20.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 16 | $7,840 | $1,584 | 20.2% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 11 | 11 | $4,290 | $1,484 | 34.6% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 12 | 13 | $3,510 | $1,397 | 39.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 32 | $3,520 | $1,210 | 34.4% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 13 | $2,470 | $781.53 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 513 | 751 | $142,690 | $44,794 | 31.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 211 | 252 | $60,480 | $19,989 | 33.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 188 | 250 | $52,500 | $17,273 | 32.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 299 | 423 | $59,220 | $14,992 | 25.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 46 | 50 | $31,000 | $11,221 | 36.2% |
About Dr. Catherine Harrell, MD
Dr. Catherine Harrell, MD is a Dermatology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1982976205.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Harrell, MD has received a total of $9,633 in payments from pharmaceutical and medical device companies, with $1,710 received in 2024. These payments were reported across 348 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,852).
As a Medicare-enrolled provider, Harrell has provided services to 7,579 Medicare beneficiaries, totaling 14,574 services with total Medicare billing of $608,710. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Internal Medicine, Dermatology
- Location Fort Worth, TX
- Active Since 02/01/2012
- Last Updated 05/09/2019
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1982976205
Products in Payments
- DUPIXENT (Biological) $2,710
- Humira (Biological) $690.42
- Sotyktu (Drug) $454.18
- COSENTYX (Biological) $388.90
- COSENTYX (Drug) $369.81
- Neo-Synalar Cream (Drug) $362.71
- OPZELURA (Drug) $339.88
- ADBRY (Biological) $330.47
- DUPIXENT (Drug) $327.65
- TALTZ (Drug) $263.82
- Tremfya (Drug) $210.14
- EPIDUO FORTE (Drug) $178.53
- DORYX (Drug) $165.03
- SKYRIZI (Biological) $158.87
- RINVOQ (Biological) $153.50
- HUMIRA (Biological) $144.89
- SOOLANTRA (Drug) $128.33
- Neo-Synalar Cream Kit (Drug) $127.52
- RHOFADE (Drug) $120.22
- Acticlate (Drug) $120.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fort Worth
Dr. Patrick Keehan, D.o, D.O
Dermatology — Payments: $761,024
Dermatology $761,024
Dr. Ronald Plott, M.d, M.D
Dermatology — Payments: $467,637
Dermatology $467,637
William Cothern, Do, DO
Dermatology — Payments: $41,403
Dermatology $41,403
Stephen Weis, Do, DO
Dermatology — Payments: $32,162
Dermatology $32,162
Kathryn Durham, Md, MD
Dermatology — Payments: $28,437
Dermatology $28,437
Mrs. Betty Rajan, M.d, M.D
Dermatology — Payments: $25,857
Dermatology $25,857